Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids 2–4 April 2004, Naarden, The Netherlands-Reference-Cited by-同舟云学术

Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids 2–4 April 2004, Naarden, The Netherlands

Published:2004-09 Issue:8-9 Volume:14 Page:526-534
ISSN:0960-8966
Container-title:Neuromuscular Disorders
language:en
Short-container-title:Neuromuscular Disorders

Author:

Bushby K.,Muntoni F.,Urtizberea A.,Hughes R.,Griggs R.

Publisher

Elsevier BV

Subject

Genetics (clinical),Neurology (clinical),Neurology,Pediatrics, Perinatology and Child Health

Reference23 articles.

1. Glucorticoid corticosteroids for Duchenne muscular dystrophy (Cochrane Review);Manzur,2004

2. Deflazacort treatment of Duchenne muscular dystrophy;Biggar;J Pediatr,2001

3. Effects of deflazacort on left ventricular function in patients with Duchenne muscular dystrophy;Silversides;Am J Cardiol,2003

4. Effect of daily prednisone on independent ambulation in patients with Duchenne dystrophy treated for up to 15 years;Pandya;Neuromusc Disord,2001

5. Randomized, double-blind six-month trial of prednisone in Duchenne muscular dystrophy;Mendell;New Engl J Med,1989

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circadian Clock in Muscle Disease Etiology and Therapeutic Potential for Duchenne Muscular Dystrophy;International Journal of Molecular Sciences;2024-04-27

2. Duchenne muscular dystrophy: disease mechanism and therapeutic strategies;Frontiers in Physiology;2023-06-26

3. Dystrophinopathies;Current Clinical Neurology;2023

4. Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy;Neuromuscular Disorders;2022-06

5. Cardiac Complications of Neuromuscular Disorders;Neuromuscular Disorders;2022